What They List
- Psilocybin Clinical Trial
- Study Screening Information
- Research Participation Details
Research
NCT05847686 - Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer
Clinical Trial in Seattle, Washington
NCT05847686 is a University of Washington Phase I/II clinical trial testing psilocybin combined with therapy for patients with metastatic cancer and cancer-related anxiety or distress. The supplied Washington dataset identifies it as the UW psilocybin cancer-related distress trial. This is a research listing, not a commercial access program.
Clinical TrialResearch
Directory Facts
- Status
- Verified from official/source records
- Price
- Free study screening / research participation
- Hours
- Verify with provider
- License / Record
- NCT05847686
- Last Verified
- 2026-06-15
Location
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington
Source Notes
Washington complete dataset reconciliation from supplied 2026-06-15 prompt.
Source: ClinicalTrials.gov NCT05847686; Washington complete dataset prompt
MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.